Triamcinolone Acetonide Extended-Release Injectable Suspension

Zilretta

NADAC/unit N/A

No Shortage

Covered Lives

Market Intelligence

2024-07-03 Class II Recall: PACIRA PHARMACEUTICALS INC

2024-06-19 Class II Recall: PACIRA PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Triamcinolone Acetonide Extended-Release Injectable Suspension drfinder.aiFind doctors who prescribe Triamcinolone Acetonide Extended-Release Injectable Suspension rxnews.aiLatest news about Triamcinolone Acetonide Extended-Release Injectable Suspension

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.